Therapy of psoriasis with retinoid plus PUVA: clinical and histologic data
- PMID: 464650
- DOI: 10.1007/BF00412661
Therapy of psoriasis with retinoid plus PUVA: clinical and histologic data
Abstract
In a group of 40 patients suffering from wide-spread psoriasis oral administration of a retinoid (Ro 10-9359) was followed by PUVA therapy. The clearance rate was increased by 30% as compared to PUVA alone. Except for cheilitis no side effects were seen. Histological analysis in 20 patients before, during and after therapy revealed an intensification of psoriatic tissue changes after retinoid treatment. Loss of corneal layers, massive exoserosis, and neutrophil migration were prominent features. Mitotic counts were not increased by the pretreatment. The increased susceptibility of diseased skin to PUVA as produced by this drug appears to be based on several factors related to the tissue changes revealed by histology.
Similar articles
-
Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative.J Invest Dermatol. 1978 Apr;70(4):178-82. doi: 10.1111/1523-1747.ep12541294. J Invest Dermatol. 1978. PMID: 641368 No abstract available.
-
[Retinoid PUVA (RePUVA): systemic combination therapy in psoriasis].Z Hautkr. 1978 Jul 15;53(14):494-504. Z Hautkr. 1978. PMID: 676424 German.
-
[Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].Hautarzt. 1983 May;34(5):229-30. Hautarzt. 1983. PMID: 6862887 German.
-
[Treatment of psoriasis using vitamin A, vitamin A acid and oral retinoids].Hautarzt. 1979 Mar;30(3):124-33. Hautarzt. 1979. PMID: 374312 Review. German.
-
Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).Am J Hosp Pharm. 1981 Jul;38(7):990-5. Am J Hosp Pharm. 1981. PMID: 7020414 Review.
Cited by
-
The retinoids. A review of their clinical pharmacology and therapeutic use.Drugs. 1987 Oct;34(4):459-503. doi: 10.2165/00003495-198734040-00003. Drugs. 1987. PMID: 3315625 Review.
-
Systematic Review and Recommendations to Combine Newer Therapies With Conventional Therapy in Psoriatic Disease.Front Med (Lausanne). 2021 Aug 19;8:696597. doi: 10.3389/fmed.2021.696597. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34490293 Free PMC article.
-
Cyclic AMP and cyclic AMP-dependent protein kinase in mouse skin. I. Systemic effects of retinoids and PUVA.Arch Dermatol Res. 1985;277(6):507-8. doi: 10.1007/BF00510073. Arch Dermatol Res. 1985. PMID: 2996446 No abstract available.
-
Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.Drugs. 1983 Jul;26(1):9-43. doi: 10.2165/00003495-198326010-00002. Drugs. 1983. PMID: 6224672 Review.
References
MeSH terms
Substances
LinkOut - more resources
Research Materials